ArticleFrontiers in immunology2024

Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors.

Mengchen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.